×
Home Companies Industry Politics Money Opinion LoungeMultimedia Science Education Sports TechnologyConsumerSpecialsMint on Sunday
×

SmithKline Beecham files lawsuit against Glenmark unit

SmithKline Beecham files lawsuit against Glenmark unit
Comment E-mail Print Share
First Published: Tue, Aug 18 2009. 05 27 PM IST
Updated: Tue, Aug 18 2009. 05 27 PM IST
Mumbai: Glenmark Pharmaceuticals Ltd said on Tuesday SmithKline Beecham Corp has filed a lawsuit for an ANDA filing for Atovaquone and Proguanil hydrochloride tablets by its US unit.
GlaxoSmithKline currently markets its products in the US as Malarone, which is used for prevention and treatment of malaria.
With this, Glenmark has four first-to-file products under litigation under the Hatch-Waxman Act, it said in a statement to the Bombay Stock Exchange (BSE).
If Glenmark successfully challenges the patents, it will be entitled to marketing exclusivity for 180 days, it added.
Shares in Glenmark were up 3.3% at Rs256 in a firm Mumbai market.
Comment E-mail Print Share
First Published: Tue, Aug 18 2009. 05 27 PM IST